StockData
ABVC BioPharma, Inc. logo

ABVC BioPharma, Inc. (ABVC) stock

ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 2/30
$0.94+0.03 (+3.30%)

Close on Nov 16, 2026Market cap $25.06MP/E –Yield –

ABVC BioPharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

ABVC BioPharma's price to book ratio was 2.5× on Nov 10, 2026, against 282.7× a year earlier. Over the last 5 years it ranged from 0.6× to 282.7×, with a median of 4.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 10, 20262.5×−219.7
2025Dec 31, 2025222.2×+217.6
2024Dec 31, 20244.6×+4.0
2023Dec 29, 20230.6×−2.8
2022Dec 30, 20223.4×−7.6
2021Dec 31, 202111.0×−73.8
2020Jan 31, 202084.8×−43.0
2019Dec 31, 2019127.8×–

More ABVC BioPharma figures

See a number that looks wrong?